These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 11120988)

  • 1. Mutation in 23S rRNA responsible for resistance to 16-membered macrolides and streptogramins in Streptococcus pneumoniae.
    Depardieu F; Courvalin P
    Antimicrob Agents Chemother; 2001 Jan; 45(1):319-23. PubMed ID: 11120988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paradoxical High-Level Spiramycin Resistance and Erythromycin Susceptibility due to 23S rRNA Mutation in
    Capitaine A; Woerther PL; Auzou M; Chachaty E; Guérin F; Giard JC; Cattoir V; Isnard C
    Microb Drug Resist; 2020 Jul; 26(7):727-731. PubMed ID: 32031922
    [No Abstract]   [Full Text] [Related]  

  • 3. Mutations in 23S rRNA and ribosomal protein L4 account for resistance in pneumococcal strains selected in vitro by macrolide passage.
    Tait-Kamradt A; Davies T; Cronan M; Jacobs MR; Appelbaum PC; Sutcliffe J
    Antimicrob Agents Chemother; 2000 Aug; 44(8):2118-25. PubMed ID: 10898684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diversity of ribosomal mutations conferring resistance to macrolides, clindamycin, streptogramin, and telithromycin in Streptococcus pneumoniae.
    Canu A; Malbruny B; Coquemont M; Davies TA; Appelbaum PC; Leclercq R
    Antimicrob Agents Chemother; 2002 Jan; 46(1):125-31. PubMed ID: 11751122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activities of telithromycin, linezolid, and quinupristin-dalfopristin against Streptococcus pneumoniae with macrolide resistance due to ribosomal mutations.
    Farrell DJ; Morrissey I; Bakker S; Buckridge S; Felmingham D
    Antimicrob Agents Chemother; 2004 Aug; 48(8):3169-71. PubMed ID: 15273142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Resistance to macrolides, lincosamides and streptogramins in infections by Streptococcus pneumoniae].
    Alonso Manzanares MA; Gutíerrez Zufiaurre MN; Muñoz Bellido JL; García-Rodríguez JA
    Med Clin (Barc); 1998 Feb; 110 Suppl 1():25-30. PubMed ID: 9717157
    [No Abstract]   [Full Text] [Related]  

  • 7. Ribosomal mutations conferring resistance to macrolides in Streptococcus pneumoniae clinical strains isolated in Germany.
    Reinert RR; Wild A; Appelbaum P; Lütticken R; Cil MY; Al-Lahham A
    Antimicrob Agents Chemother; 2003 Jul; 47(7):2319-22. PubMed ID: 12821488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two new mechanisms of macrolide resistance in clinical strains of Streptococcus pneumoniae from Eastern Europe and North America.
    Tait-Kamradt A; Davies T; Appelbaum PC; Depardieu F; Courvalin P; Petitpas J; Wondrack L; Walker A; Jacobs MR; Sutcliffe J
    Antimicrob Agents Chemother; 2000 Dec; 44(12):3395-401. PubMed ID: 11083646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrolide resistance by ribosomal mutation in clinical isolates of Streptococcus pneumoniae from the PROTEKT 1999-2000 study.
    Farrell DJ; Douthwaite S; Morrissey I; Bakker S; Poehlsgaard J; Jakobsen L; Felmingham D
    Antimicrob Agents Chemother; 2003 Jun; 47(6):1777-83. PubMed ID: 12760848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro selection of mutants of Streptococcus pneumoniae resistant to macrolides and linezolid: relationship with susceptibility to penicillin G or macrolides.
    Carsenti-Dellamonica H; Galimand M; Vandenbos F; Pradier C; Roger PM; Dunais B; Sabah M; Mancini G; Dellamonica P
    J Antimicrob Chemother; 2005 Oct; 56(4):633-42. PubMed ID: 16135525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro antibacterial activity of α-methoxyimino acylide derivatives against macrolide-resistant pathogens and mutation analysis in 23S rRNA.
    Sugiyama H; Yoshida I; Ueki M; Tanabe K; Manaka A; Hiramatsu K
    J Antibiot (Tokyo); 2017 Mar; 70(3):264-271. PubMed ID: 28074049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time-kill study of the activity of telithromycin against macrolide-resistant Streptococcus pneumoniae Isolates with 23S rRNA mutations and changes in ribosomal proteins L4 and L22.
    Reinert RR; Al-Lahham A
    Antimicrob Agents Chemother; 2005 Jul; 49(7):3011-3. PubMed ID: 15980387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in 23S rRNA account for intrinsic resistance to macrolides in Mycoplasma hominis and Mycoplasma fermentans and for acquired resistance to macrolides in M. hominis.
    Pereyre S; Gonzalez P; De Barbeyrac B; Darnige A; Renaudin H; Charron A; Raherison S; Bébéar C; Bébéar CM
    Antimicrob Agents Chemother; 2002 Oct; 46(10):3142-50. PubMed ID: 12234836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004).
    Wierzbowski AK; Nichol K; Laing N; Hisanaga T; Nikulin A; Karlowsky JA; Hoban DJ; Zhanel GG
    J Antimicrob Chemother; 2007 Oct; 60(4):733-40. PubMed ID: 17673477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predominance of 23S rRNA mutants among non-erm, non-mef macrolide-resistant clinical isolates of Streptococcus pneumoniae collected in the United States in 1999-2000.
    Davies TA; Bush K; Sahm D; Evangelista A
    Antimicrob Agents Chemother; 2005 Jul; 49(7):3031-3. PubMed ID: 15980393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneous macrolide resistance and gene conversion in the pneumococcus.
    Wolter N; Smith AM; Farrell DJ; Klugman KP
    Antimicrob Agents Chemother; 2006 Jan; 50(1):359-61. PubMed ID: 16377711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of ribosome methylation in MLS-resistant Streptococcus pneumoniae by macrolides and ketolides.
    Zhong P; Cao Z; Hammond R; Chen Y; Beyer J; Shortridge VD; Phan LY; Pratt S; Capobianco J; Reich KA; Flamm RK; Or YS; Katz L
    Microb Drug Resist; 1999; 5(3):183-8. PubMed ID: 10566867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro development of resistance to telithromycin (HMR 3647), four macrolides, clindamycin, and pristinamycin in Streptococcus pneumoniae.
    Davies TA; Dewasse BE; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2000 Feb; 44(2):414-7. PubMed ID: 10639373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and characterization of the mechanisms of macrolide, lincosamide, and streptogramin resistance in isolates of Streptococcus pneumoniae.
    Johnston NJ; De Azavedo JC; Kellner JD; Low DE
    Antimicrob Agents Chemother; 1998 Sep; 42(9):2425-6. PubMed ID: 9736575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of a Streptococcus pneumoniae isolate resistant to streptogramins by mutation in ribosomal protein L22 during pristinamycin therapy of pneumococcal pneumonia.
    Cattoir V; Merabet L; Legrand P; Soussy CJ; Leclercq R
    J Antimicrob Chemother; 2007 May; 59(5):1010-2. PubMed ID: 17434877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.